Pfizer Inc (PFE)

$25.21 -0.71 (-2.74%)
Market Cap 148.41B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.51
Forward PE 8.72
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 119,614,300
Avg Vol 36,494,223
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 17%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Orchard
Orchard Jun. 19 at 11:33 AM
$MRNA $JNJ $PFE Wow! Tulsi drops the bomb on the Covid lies. And morons still believe Big Pharma would never hide adverse effect from a “gene therapy” But 5 years ago I was the conspiracy theorists. Every day more vindication. I trust Strip Club operator $RICK more than these drug firms. How’s that safe Oxy working out? That asbestos baby powder, cancer causing sunscreen…..
1 · Reply
TraderinDarkPool
TraderinDarkPool Jun. 19 at 3:22 AM
$PFE
0 · Reply
TraderinDarkPool
TraderinDarkPool Jun. 19 at 3:22 AM
$PFE 🛑🛑🛑🛑read!! The word is out and cannot be suppressed any longer
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 19 at 12:25 AM
$PFE On behalf of all pfizer shareholders, I would like to thank the US government for continuing to invent new holidays. Idk what the teenth of June is but it keeps us safe from the market for one more day!
1 · Reply
Willieberich
Willieberich Jun. 19 at 12:14 AM
$PFE nothing to look at here! Big position. Will buy more on Monday if it's still at this level .don't listen to the same old talking heads on pfe stocktwits .1 acts like he's an owner of the shares and complains no matter what .and another comes on just complaining .just buy .25 is the floor .proven over and over .the real buyers aren't selling for tech .we own both .and aren't chasing....
0 · Reply
History101
History101 Jun. 18 at 11:51 PM
$SLS i believe it will be $MRK, especially since $RVMD said no to MRK's buyout offer earlier this year. CNBC's "Fast Money" had a biotech IPO segment tonight, and the guest biotech analyst said that he did not see $PFE doing any more big deals because PFE is already levered up with the $40B acquisition they did not too long ago. The guest analyst DID think MRK could do more buying.
1 · Reply
Ro_Patel
Ro_Patel Jun. 18 at 11:31 PM
Today's option volume of 87.8M contracts was +15.00% above recent avg levels, w/ calls leading puts 5 to 4 Single stock (47.2M contracts) & ETF products (34.5M contracts) saw relatively heavy volume, while index flow (6.1M contracts) was moderate Today's most active sectors included Utilities, Health Care, & Energy, while Basic Materials & Industrials were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 208 & lower for 239 Unusual total option volume was observed in $INTC $MSTR $HIMS $FRMI & $PFE Top 5 single stock contract volumes: - NVDA: puts: 1.47M / calls: 2.56M / Total: 4.02M - TSLA: puts: 1.58M / calls: 1.99M / Total: 3.57M - SPCX: puts: 1.06M / calls 1.13M / Total: 2.19M - AAPL: puts: 639K / calls: 966K / Total: 1.6M - INTC: puts: 497K / calls: 968K / Total: 1.46M
0 · Reply
TruthTrader
TruthTrader Jun. 18 at 11:23 PM
$KLAC $PFE $STRC $WKSP super low float but not liquid. End up getting stick in your position.
0 · Reply
StUngarjr
StUngarjr Jun. 18 at 9:53 PM
$PFE This is a distinct possibility now, though I hope not. New CFO comes in without being bound by past promises. Throws in a kitchen sink quarter, then sets bar lower to make his job easier, which allows him to slash the dividend by more than half justifying it by telling street it’s for future growth. Stock becomes a teenager and all the so called conservative value people tell you what a great buy it is now and to average down even more. Good Luck Value trappers
2 · Reply
mikesterz7
mikesterz7 Jun. 18 at 9:26 PM
$PFE Pfizer said Executive Vice President and Chief Financial Officer Dave Denton notified the company on June 16 that he will step down effective August 15.
0 · Reply
Latest News on PFE
Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 17 hours ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit

Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 18 hours ago

Pfizer reaffirms all components of FY26 guidance

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

2026-06-18T10:52:33.000Z - 1 day ago

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 1 day ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 1 day ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 9 days ago

Pfizer CEO warns German investment at risk over drug pricing policies

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

2026-06-09T21:05:52.000Z - 9 days ago

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

2026-06-09T21:05:12.000Z - 9 days ago

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 9 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 9 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 10 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 10 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 11 days ago

Pfizer says FDA approves expanded indication for Hympavzi

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 11 days ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 11 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 11 days ago

Pfizer presents results from Phase 2b studies of berobenatide

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 12 days ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 12 days ago

Pfizer Slides: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 12 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 12 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 14 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 15 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 15 days ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 17 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

2026-05-31T13:45:07.000Z - 18 days ago

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

2026-05-31T13:25:52.000Z - 18 days ago

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 18 days ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 19 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 19 days ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Pfizer announces seven-year follow-up results from Phase 3 CROWN trial

2026-05-29T13:17:15.000Z - 20 days ago

Pfizer announces seven-year follow-up results from Phase 3 CROWN trial

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 20 days ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 21 days ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 21 days ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Pfizer enters into global strategic collaboration with Innovent Biologics

2026-05-28T23:05:16.000Z - 21 days ago

Pfizer enters into global strategic collaboration with Innovent Biologics

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 21 days ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 21 days ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 22 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 4 weeks ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 4 weeks ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 4 weeks ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 18, 2026, 8:00 AM EDT - 4 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 5 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 5 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 5 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 6 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 6 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 6 weeks ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings release: Q1 2026

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Quarterly report: Q1 2026

Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Slides: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 6 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 6 weeks ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 6 weeks ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 6 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 6 weeks ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 6 weeks ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 6 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 7 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 7 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 7 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 7 weeks ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 2 months ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 2 months ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 2 months ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 2 months ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Orchard
Orchard Jun. 19 at 11:33 AM
$MRNA $JNJ $PFE Wow! Tulsi drops the bomb on the Covid lies. And morons still believe Big Pharma would never hide adverse effect from a “gene therapy” But 5 years ago I was the conspiracy theorists. Every day more vindication. I trust Strip Club operator $RICK more than these drug firms. How’s that safe Oxy working out? That asbestos baby powder, cancer causing sunscreen…..
1 · Reply
TraderinDarkPool
TraderinDarkPool Jun. 19 at 3:22 AM
$PFE
0 · Reply
TraderinDarkPool
TraderinDarkPool Jun. 19 at 3:22 AM
$PFE 🛑🛑🛑🛑read!! The word is out and cannot be suppressed any longer
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 19 at 12:25 AM
$PFE On behalf of all pfizer shareholders, I would like to thank the US government for continuing to invent new holidays. Idk what the teenth of June is but it keeps us safe from the market for one more day!
1 · Reply
Willieberich
Willieberich Jun. 19 at 12:14 AM
$PFE nothing to look at here! Big position. Will buy more on Monday if it's still at this level .don't listen to the same old talking heads on pfe stocktwits .1 acts like he's an owner of the shares and complains no matter what .and another comes on just complaining .just buy .25 is the floor .proven over and over .the real buyers aren't selling for tech .we own both .and aren't chasing....
0 · Reply
History101
History101 Jun. 18 at 11:51 PM
$SLS i believe it will be $MRK, especially since $RVMD said no to MRK's buyout offer earlier this year. CNBC's "Fast Money" had a biotech IPO segment tonight, and the guest biotech analyst said that he did not see $PFE doing any more big deals because PFE is already levered up with the $40B acquisition they did not too long ago. The guest analyst DID think MRK could do more buying.
1 · Reply
Ro_Patel
Ro_Patel Jun. 18 at 11:31 PM
Today's option volume of 87.8M contracts was +15.00% above recent avg levels, w/ calls leading puts 5 to 4 Single stock (47.2M contracts) & ETF products (34.5M contracts) saw relatively heavy volume, while index flow (6.1M contracts) was moderate Today's most active sectors included Utilities, Health Care, & Energy, while Basic Materials & Industrials were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 208 & lower for 239 Unusual total option volume was observed in $INTC $MSTR $HIMS $FRMI & $PFE Top 5 single stock contract volumes: - NVDA: puts: 1.47M / calls: 2.56M / Total: 4.02M - TSLA: puts: 1.58M / calls: 1.99M / Total: 3.57M - SPCX: puts: 1.06M / calls 1.13M / Total: 2.19M - AAPL: puts: 639K / calls: 966K / Total: 1.6M - INTC: puts: 497K / calls: 968K / Total: 1.46M
0 · Reply
TruthTrader
TruthTrader Jun. 18 at 11:23 PM
$KLAC $PFE $STRC $WKSP super low float but not liquid. End up getting stick in your position.
0 · Reply
StUngarjr
StUngarjr Jun. 18 at 9:53 PM
$PFE This is a distinct possibility now, though I hope not. New CFO comes in without being bound by past promises. Throws in a kitchen sink quarter, then sets bar lower to make his job easier, which allows him to slash the dividend by more than half justifying it by telling street it’s for future growth. Stock becomes a teenager and all the so called conservative value people tell you what a great buy it is now and to average down even more. Good Luck Value trappers
2 · Reply
mikesterz7
mikesterz7 Jun. 18 at 9:26 PM
$PFE Pfizer said Executive Vice President and Chief Financial Officer Dave Denton notified the company on June 16 that he will step down effective August 15.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 18 at 8:54 PM
$PFE we were 1 letter off being up 20% today
3 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 18 at 8:15 PM
$PFE insane AH volume
3 · Reply
superpiterpan
superpiterpan Jun. 18 at 8:08 PM
$PFE 30mln shares at closing? Who dumped that much?
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 18 at 8:04 PM
$PFE worthless
0 · Reply
Zurek4
Zurek4 Jun. 18 at 7:55 PM
$PFE 8 million buy imbalance
0 · Reply
notreload_ai
notreload_ai Jun. 18 at 7:47 PM
$PFE announced that CFO Dave Denton will leave the company on August 15, 2026, for a new role in consumer goods. Cecile Guegan named Interim CFO as the company reaffirms its 2026 guidance. https://notreload.xyz/xy/pfizer-announces-departure-of-cfo-dave-denton-names-interim-successor/
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 18 at 7:44 PM
$PFE
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 18 at 7:42 PM
$PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 18 at 7:37 PM
$PFE no of course not, they still short every pop
0 · Reply
superpiterpan
superpiterpan Jun. 18 at 7:36 PM
$PFE started new pos, 10,000 shares. Target 20,000
1 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 18 at 7:33 PM
$PFE can we get a pity strong close?
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Jun. 18 at 7:32 PM
$PFE At this rate, were going to be red for the next three days...
0 · Reply